Methods and compositions for cancer treatment
US-2024424094-A1 · Dec 26, 2024 · US
Pharmaceutical formulations comprising paraoxonase
US9050331B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9050331-B2 |
| Application number | US-58851305-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 4, 2005 |
| Priority date | Feb 4, 2004 |
| Publication date | Jun 9, 2015 |
| Grant date | Jun 9, 2015 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides a pharmaceutical formulation comprising paraoxonase (PON), a purification and stabilization method of PON, and an agent for prophylactic and/or therapeutic treatment of a disease resulting from ischemia reperfusion and/or cerebral infarction containing PON as an active ingredient.
First claim
Opening claim text (preview).
What is claimed is: 1. A method for improving prognosis, neurological symptoms, or motor dysfunction of a disease resulting from cerebral infarction, comprising: intravenously administering an effective amount of paraoxonase in combination with an effective amount of 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate to improve one of prognosis, neurological symptoms and motor dysfunction of a disease resulting from cerebral infarction to a patient in need thereof, wherei…
Assignees
Inventors
Classifications
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
- A61K38/465Primary
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9050331B2 cover?
- The present invention provides a pharmaceutical formulation comprising paraoxonase (PON), a purification and stabilization method of PON, and an agent for prophylactic and/or therapeutic treatment of a disease resulting from ischemia reperfusion and/or cerebral infarction containing PON as an active ingredient.
- Who is the assignee on this patent?
- Asahara Naomi, Hashimoto Motonori, Yuki Satoshi, and 1 more
- What technology area does this patent fall under?
- Primary CPC classification A61K38/465. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Jun 09 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).